Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma
Jin, Yi, Chen, Kenian, De Paepe, Ayla, Hellqvist, Eva, Krstic, Aleksandra D., Metang, Lauren, Gustafsson, Charlotte, Davis, Richard E., Levy, Yair M., Surapaneni, Rakesh, Wallblom, Ann, Nahi, Hareth, Mansson, Robert, Lin, Yin C.
Published in Blood (10.05.2018)
Published in Blood (10.05.2018)
Get full text
Journal Article
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
Gerber, David E., Segal, Jodi B., Levy, M. Yair, Kane, Joyce, Jones, Richard J., Streiff, Michael B.
Published in Blood (01.08.2008)
Published in Blood (01.08.2008)
Get full text
Journal Article
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
Zeidner, Joshua F, Foster, Matthew C, Blackford, Amanda L, Litzow, Mark R, Morris, Lawrence E, Strickland, Stephen A, Lancet, Jeffrey E, Bose, Prithviraj, Levy, M Yair, Tibes, Raoul, Gojo, Ivana, Gocke, Christopher D, Rosner, Gary L, Little, Richard F, Wright, John J, Doyle, L Austin, Smith, B Douglas, Karp, Judith E
Published in Haematologica (Roma) (01.09.2015)
Published in Haematologica (Roma) (01.09.2015)
Get full text
Journal Article
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)
Zeidner, Joshua F., Foster, Matthew C., Blackford, Amanda L., Litzow, Mark R., Morris, Lawrence E., Strickland, Stephen A., Lancet, Jeffrey E., Bose, Prithviraj, Levy, M. Yair, Tibes, Raoul, Gojo, Ivana, Gocke, Christopher D., Rosner, Gary L., Little, Richard F., Wright, John J., Doyle, L. Austin, Smith, B. Douglas, Karp, Judith E.
Published in Leukemia research (01.09.2018)
Published in Leukemia research (01.09.2018)
Get full text
Journal Article
Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies
Get full text
Journal Article
Book Review
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
Zeidan, Amer M, Knaus, Hanna A, Robinson, Tara M, Towlerton, Andrea M H, Warren, Edus H, Zeidner, Joshua F, Blackford, Amanda L, Duffield, Amy S, Rizzieri, David, Frattini, Mark G, Levy, Yair M, Schroeder, Mark A, Ferguson, Anna, Sheldon, Katherine E, DeZern, Amy E, Gojo, Ivana, Gore, Steven D, Streicher, Howard, Luznik, Leo, Smith, B Douglas
Published in Clinical cancer research (01.08.2018)
Published in Clinical cancer research (01.08.2018)
Get full text
Journal Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Zeidner, Joshua F., Lin, Tara L., Vigil, Carlos E., Fine, Gil, Yair Levy, M., Nazha, Aziz, Esteve, Jordi, Lee, Daniel J., Yee, Karen, Dalovisio, Andrew, Wang, Eunice S., Bergua Burgues, Juan M., Schriber, Jeffrey, Litzow, Mark R., Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, Douglas Smith, B.
Published in Blood cancer journal (New York) (30.10.2021)
Published in Blood cancer journal (New York) (30.10.2021)
Get full text
Journal Article
P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST‐IN‐CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2‐MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND‐01 TRIAL
Martinelli, G., Santoro, A., Gambacorti‐Passerini, C., Vives Polo, S., Solomon, S. R., Mukherjee, S., Lech‐Maranda, E., Yair Levy, M., Wierzbowska, A., Calbacho‐Robles, M., Marconi, G., Benedetta Giannini, M., Cano, I., Torres Miñana, L., Acuña‐Cruz, E., Angelosanto, N., Galleu, A., Baldini, S., Blotta, S., Ravandi, F., Montesinos, P.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Acalabrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): Results of a phase 2, multicenter, open-label trial
Budde, L Elizabeth, Coleman, Morton, Stevens, Don A., Ma, Shuo, Patti, Caterina, Levy, M. Yair, Lossos, Izidore S., Geethakumari, Praveen Ramakrishnan, Lam, Selay, Calvo, Roser, Higgins, Kara, Strati, Paolo
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1/2 study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in patients with IDH1/2 -mutated acute myeloid leukemia: The DIAMOND-01 trial
Martinelli, Giovanni, Santoro, Armando, Gambacorti-Passerini, Carlo, Vives Polo, Susana, Solomon, Scott R., Mukherjee, Sudipto, Levy, M. Yair, Wierzbowska, Agnieszka, Calbacho, Maria, Angelosanto, Noemi, Galleu, Antonio, Baldini, Simone, Blotta, Simona, Habboubi, Nassir, Ravandi, Farhad, Montesinos, Pau
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Randomized multicenter phase II trial of timed-sequential therapy with flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus “7+3” for adults with newly diagnosed acute myeloid leukemia (AML)
Zeidner, Joshua F., Foster, Matthew C., Blackford, Amanda, Litzow, Mark Robert, Morris, Lawrence, Strickland, Stephen Anthony, Lancet, Jeffrey E., Bose, Prithviraj, Levy, M. Yair, Tibes, Raoul, Gojo, Ivana, Gocke, Christopher D, Rosner, Gary L., Greer, Jacqueline, Cain, Joan M, Little, Richard F., Wright, John Joseph, Doyle, L. Austin, Smith, B Douglas, Karp, Judith E.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Venous Thromboembolism among 1,570 Patients Undergoing Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment and Outcomes
Gerber, David E., Segal, Jodi B., Levy, M. Yair, Kane, Joyce M., Jones, Richard J., Streiff, Michael B.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Low Incidence of CMV Reactivation and Infection after Allogeneic Bone Marrow Transplantation (BMT) Incorporating Post-Transplantation Cyclophosphamide (Cy)
Symons, Heather J., Luznik, Leo, Phelps, Michele, Crawford, Angelita, McIntyre, Katherine, Levy, M. Yair, Jones, Richard J., Fuchs, Ephraim J.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Impact of Killer Immunoglobulin Receptor (KIR) Ligand Incompatibility in Nonmyeloablative Bone Marrow Transplantation (BMT) from Haploidentical Donors
Symons, Heather J., Leffell, M. Sue, Rossiter, Nancy D., Sugar, Elizabeth, Luznik, Leo, Phelps, Michele, Crawford, Angelita, Levy, M. Yair, Jones, Richard J., Fuchs, Ephraim J.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Low Incidence of CMV Reactivation and Infectious Morbidity and Mortality after Nonmyeloablative Haploidentical Bone Marrow Transplantation Incorporating Post-Transplantation Cyclophosphamide
Symons, Heather J., Ye, Xiaobu, Luznik, Leo, Phelps, Michele, Crawford, Angelita, Levy, M. Yair, Jones, Richard J., Fuchs, Ephraim J.
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article